These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 19086767

  • 1. Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.
    Rothman RB, Blough BE, Baumann MH.
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):458-74. PubMed ID: 19086767
    [Abstract] [Full Text] [Related]

  • 2. Dopamine/serotonin releasers as medications for stimulant addictions.
    Rothman RB, Blough BE, Baumann MH.
    Prog Brain Res; 2008 Dec; 172():385-406. PubMed ID: 18772043
    [Abstract] [Full Text] [Related]

  • 3. Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.
    Rothman RB, Blough BE, Baumann MH.
    AAPS J; 2007 Jan 05; 9(1):E1-10. PubMed ID: 17408232
    [Abstract] [Full Text] [Related]

  • 4. Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs.
    Rothman RB, Baumann MH.
    Ann N Y Acad Sci; 2006 Aug 05; 1074():245-60. PubMed ID: 17105921
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys.
    Banks ML, Bauer CT, Blough BE, Rothman RB, Partilla JS, Baumann MH, Negus SS.
    Exp Clin Psychopharmacol; 2014 Jun 05; 22(3):274-284. PubMed ID: 24796848
    [Abstract] [Full Text] [Related]

  • 7. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA, Hope O, Okonji C, Rahni DN, Zhou Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan 05; 28(1):157-71. PubMed ID: 14687870
    [Abstract] [Full Text] [Related]

  • 8. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.
    Rothman RB, Blough BE, Woolverton WL, Anderson KG, Negus SS, Mello NK, Roth BL, Baumann MH.
    J Pharmacol Exp Ther; 2005 Jun 05; 313(3):1361-9. PubMed ID: 15761112
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction.
    Rothman RB, Blough BE, Baumann MH.
    Trends Pharmacol Sci; 2006 Dec 05; 27(12):612-8. PubMed ID: 17056126
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Appetite suppressants as agonist substitution therapies for stimulant dependence.
    Rothman RB, Blough BE, Baumann MH.
    Ann N Y Acad Sci; 2002 Jun 05; 965():109-26. PubMed ID: 12105089
    [Abstract] [Full Text] [Related]

  • 14. The serotonergic system and its role in cocaine addiction.
    Filip M, Frankowska M, Zaniewska M, Gołda A, Przegaliński E.
    Pharmacol Rep; 2005 Jun 05; 57(6):685-700. PubMed ID: 16382187
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.
    Bauer CT, Banks ML, Blough BE, Negus SS.
    Br J Pharmacol; 2013 Feb 05; 168(4):850-62. PubMed ID: 22978626
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.
    Ago Y, Nakamura S, Baba A, Matsuda T.
    J Pharmacol Sci; 2008 Jan 05; 106(1):15-21. PubMed ID: 18198473
    [Abstract] [Full Text] [Related]

  • 20. Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction.
    Rothman RB, Elmer GI, Shippenberg TS, Rea W, Baumann MH.
    Ann N Y Acad Sci; 1998 May 30; 844():59-74. PubMed ID: 9668665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.